|Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence|
ST Cole, R Brosch, J Parkhill, T Garnier, C Churcher, D Harris, SV Gordon, ...
Nature 396 (6707), 190-190, 1998
|The spectrum of latent tuberculosis: rethinking the biology and intervention strategies|
CE Barry 3rd, HI Boshoff, V Dartois, T Dick, S Ehrt, JA Flynn, ...
Nature Reviews Microbiology 7 (12), 845-855, 2009
|A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis|
CK Stover, P Warrener, DR VanDevanter, DR Sherman, TM Arain, ...
Nature 405 (6789), 962-966, 2000
|A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response|
MB Reed, P Domenech, C Manca, H Su, AK Barczak, BN Kreiswirth, ...
Nature 431 (7004), 84-87, 2004
|Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk|
KD Mayer-Barber, BB Andrade, SD Oland, EP Amaral, DL Barber, ...
Nature 511 (7507), 99-103, 2014
|Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β|
C Manca, L Tsenova, A Bergtold, S Freeman, M Tovey, JM Musser, ...
Proceedings of the National Academy of Sciences 98 (10), 5752-5757, 2001
|Mycolic acids: structure, biosynthesis and physiological functions|
CE Barry Iii, RE Lee, K Mdluli, AE Sampson, BG Schroeder, RA Slayden, ...
Progress in lipid research 37 (2-3), 143-179, 1998
|PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release|
R Singh, U Manjunatha, HIM Boshoff, YH Ha, P Niyomrattanakit, ...
Science 322 (5906), 1392-1395, 2008
|The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action|
HIM Boshoff, TG Myers, BR Copp, MR McNeil, MA Wilson, CE Barry
Journal of Biological Chemistry 279 (38), 40174-40184, 2004
|Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates|
LE Via, PL Lin, SM Ray, J Carrillo, SS Allen, SY Eum, K Taylor, E Klein, ...
Infection and immunity 76 (6), 2333-2340, 2008
|Tuberculosis: what we don’t know can, and does, hurt us|
DG Russell, CE Barry 3rd, JAL Flynn
Science 328 (5980), 852-856, 2010
|Linezolid for treatment of chronic extensively drug-resistant tuberculosis|
M Lee, J Lee, MW Carroll, H Choi, S Min, T Song, LE Via, LC Goldfeder, ...
New England Journal of Medicine 367 (16), 1508-1518, 2012
|The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages|
JJ De Voss, K Rutter, BG Schroeder, H Su, YQ Zhu, CE Barry III
Proceedings of the National Academy of Sciences 97 (3), 1252-1257, 2000
|Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis|
W Shi, X Zhang, X Jiang, H Yuan, JS Lee, CE Barry 3rd, H Wang, ...
Science 333 (6049), 1630-1632, 2011
|Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid|
K Mdluli, RA Slayden, YQ Zhu, S Ramaswamy, X Pan, D Mead, DD Crane, ...
Science 280 (5369), 1607-1610, 1998
|Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis|
JE Hugonnet, LW Tremblay, HI Boshoff, CE Barry 3rd, JS Blanchard
Science 323 (5918), 1215-1218, 2009
|Tuberculosis—metabolism and respiration in the absence of growth|
HIM Boshoff, CE Barry 3rd
Nature Reviews Microbiology 3 (1), 70-80, 2005
|Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis|
DR Sherman, K Mdluli, MJ Hickey, TM Arain, SL Morris, CE Barry III, ...
Science 272 (5268), 1641-1643, 1996
|Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB|
SY Eum, JH Kong, MS Hong, YJ Lee, JH Kim, SH Hwang, SN Cho, LE Via, ...
Chest 137 (1), 122-128, 2010
|Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage|
M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ...
Nature genetics 47 (3), 242-249, 2015